Digital Therapeutics Market Sale to hit US$ 17.7 Billion by 2027 and expand at a CAGR of 31.6 %, says MarketsandMarkets™
The Digital Therapeutics Market is growing rapidly as more companies look to provide digital solutions for healthcare needs.
Digital therapeutics are a new type of medical treatment that use digital technology to improve the health outcomes of patients. The digital therapeutics market is growing rapidly, with more companies entering the space each year. As the technology becomes more sophisticated and cost-effective, digital therapeutics are becoming more popular as an alternative to traditional treatments.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724
Digital therapeutics are most commonly used to treat chronic conditions such as diabetes, obesity, asthma, hypertension, and depression. These treatments use digital technology to monitor patient progress and provide personalized treatment plans. Digital therapeutics are often used in conjunction with traditional treatments, such as medications and lifestyle changes, to help patients achieve better health outcomes.
The digital therapeutics market is projected to grow significantly in the coming years. This growth is being driven by increased awareness of the potential benefits of digital therapeutics, advances in technology, and increased investment in the sector.
Digital therapeutics are also becoming increasingly popular for preventative care and disease management. Companies are developing digital therapeutics that can monitor patient health and provide tailored advice to help patients improve their health and lifestyle.
The digital therapeutics market is expected to reach $17.7 billion by 2027, according to a report from marketsandmarkets. This growth will be driven by the increasing demand for digital therapeutics, the continued development of more sophisticated treatments, and the increasing adoption of digital therapies among healthcare providers.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724
Digital therapeutics are revolutionizing the way healthcare is delivered. As more companies enter the market and develop innovative treatments, the digital therapeutics market is expected to continue to grow. This growth will create new opportunities for patients, healthcare providers, and companies alike.
North America is expected to hold the largest share of the digital therapeutics market in 2022
The digital therapeutics market has been segmented into four main regional segments: North America, Europe, the Asia Pacific, and Rest of the World. North America is expected to hold the largest share of this market, followed by Europe in 2022. The market in North America is also expected to grow at the highest CAGR. The large share can be attributed to the rising number of new start-ups in digital therapeutics market and slowly developing reimbursement structures for digital therapeutics solutions.
Key Market Players
Prominent players in the digital therapeutics market include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Pear Therapeutics, Inc. (US), CogniFit Inc (US), Ginger (US), Propeller Health (US), 2Morrow, Inc. (US), Canary Health (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Twill Inc. (US), Better Therapeutics, Inc (US), Mindstrong (US), Kaia Health (Germany), BehaVR Inc (US), Ayogo (Canada), Mindable Health GmbH (Germany), Virta Health Corp (US), Hinge Health, Inc. (US), Orexo AB (Sweden) and Freespira (US).
Don’t miss out on business opportunities in Digital Therapeutics (DTx) Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51646724
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian